233 related articles for article (PubMed ID: 32144838)
1. Utilization of deceased organ donors based on HIV, hepatitis B virus, and hepatitis C virus screening test results.
Theodoropoulos N; Kroll-Desrosiers A; Ison MG
Transpl Infect Dis; 2020 Aug; 22(4):e13275. PubMed ID: 32144838
[TBL] [Abstract][Full Text] [Related]
2. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results.
Theodoropoulos N; Nowicki MJ; Chinchilla-Reyes C; Dionne S; Jaramillo A; Mone T; Hasz R; Jendrisak MD; Ladner DP; Ison MG
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178242
[TBL] [Abstract][Full Text] [Related]
3. Deceased organ donor screening for HIV, hepatitis B, and hepatitis C viruses: a survey of organ procurement organization practices.
Theodoropoulos N; Jaramillo A; Ladner DP; Ison MG
Am J Transplant; 2013 Aug; 13(8):2186-90. PubMed ID: 23711196
[TBL] [Abstract][Full Text] [Related]
4. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.
Irwin L; Kotton CN; Elias N; Palafox J; Basler D; Shao SH; Lester W; Zhang X; Kimball B; Trencher C; Fishman JA
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28994164
[TBL] [Abstract][Full Text] [Related]
5. Deceased tissue donor serology and molecular testing for HIV, hepatitis B and hepatitis C viruses: a lack of cadaveric validated tests.
Victer TN; Dos Santos CS; Báo SN; Sampaio TL
Cell Tissue Bank; 2016 Dec; 17(4):543-553. PubMed ID: 27329292
[TBL] [Abstract][Full Text] [Related]
6. Impact of repeat testing of living kidney donors within 14 days of the transplant procedure: a multicenter retrospective survey.
Echenique IA; Cohen D; Rudow DL; Ison MG
Transpl Infect Dis; 2014 Jun; 16(3):403-11. PubMed ID: 24796964
[TBL] [Abstract][Full Text] [Related]
7. Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.
Jones JM; Kracalik I; Levi ME; Bowman JS; Berger JJ; Bixler D; Buchacz K; Moorman A; Brooks JT; Basavaraju SV
MMWR Recomm Rep; 2020 Jun; 69(4):1-16. PubMed ID: 32584804
[TBL] [Abstract][Full Text] [Related]
8. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe.
Mafirakureva N; Mapako T; Khoza S; Emmanuel JC; Marowa L; Mvere D; Postma MJ; van Hulst M
Transfusion; 2016 Dec; 56(12):3101-3111. PubMed ID: 27696441
[TBL] [Abstract][Full Text] [Related]
10. Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
Pruett TL; Clark MA; Taranto SE
Transplantation; 2017 Jul; 101(7):1670-1678. PubMed ID: 28252560
[TBL] [Abstract][Full Text] [Related]
11. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.
Mine H; Emura H; Miyamoto M; Tomono T; Minegishi K; Murokawa H; Yamanaka R; Yoshikawa A; Nishioka K;
J Virol Methods; 2003 Sep; 112(1-2):145-51. PubMed ID: 12951223
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015).
Fiedler SA; Oberle D; Chudy M; Scheiblauer H; Henseler O; Halbauer J; Heiden M; Funk M
Vox Sang; 2019 Jul; 114(5):443-450. PubMed ID: 31012114
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.
Yang MH; Li L; Hung YS; Hung CS; Allain JP; Lin KS; Tsai SJ
Transfusion; 2010 Jan; 50(1):65-74. PubMed ID: 19709394
[TBL] [Abstract][Full Text] [Related]
15. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
16. Screening recipients of increased-risk donor organs: a survey of transplant infectious diseases physician practices.
Theodoropoulos N; Ladner DP; Ison MG
Transpl Infect Dis; 2013 Oct; 15(5):545-9. PubMed ID: 23901896
[TBL] [Abstract][Full Text] [Related]
17. Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation.
Seem DL; Lee I; Umscheid CA; Kuehnert MJ
Am J Transplant; 2013 Aug; 13(8):1953-62. PubMed ID: 23890284
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Deceased Solid Organ Donors and Screening Results for Hepatitis B, C, and Human Immunodeficiency Viruses - United States, 2010-2017.
Abara WE; Collier MG; Moorman A; Bixler D; Jones J; Annambhotla P; Bowman J; Levi ME; Brooks JT; Basavaraju SV
MMWR Morb Mortal Wkly Rep; 2019 Jan; 68(3):61-66. PubMed ID: 30677008
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden.
Davidson T; Ekermo B; Gaines H; Lesko B; Åkerlind B
Transfusion; 2011 Feb; 51(2):421-9. PubMed ID: 20849409
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
